Norlase is looking to fill a key role for the next stage of our journey: Vice President of Quality Assurance and Regulatory Affairs. This person will be responsible for regulatory approval of our medical laser products and will be essential in building a quality-centered organization, as we continue to grow.
If you have QA & RA experience and are motivated by building a global high-tech company from the early stage, you might be exactly who we are looking for. To see the full job post click here.
Will you be attending the World of Photonics Trade Fair in Munich from June 26 – 29? If so, we invite you to stop by Booth 625 (Hall B1) for a first-hand look at the AuroraOne family of next-generation visible sources that enable more convenient, effective and cost-efficient systems.
While at the event, don’t miss the Norlase presentation during “Space meets LASER World of PHOTONICS”, part of the Start-up World Program on Wednesday afternoon:
To schedule an appointment with us during World of Photonics, or to learn more about Norlase’s products and demo program, feel free to reach out at email@example.com.
Looking forward to seeing you in Munich, or hearing from you about your laser application!
Norlase is hiring a Postdoc within high-power semiconductor lasers. The position offers a unique combination of academic and entrepreneurial experience, within Denmark’s leading photonics start-up.
In addition to holding a Ph.D. in laser physics or technology, you must have been located outside of Denmark for the past 3 years – and have a taste for adventure. To see the full vacancy notice, click here.
Feeling uninspired by ordinary, everyday lasers? Norlase is ‘Making Lasers Great Again’! and we will be at Photonics West 2017 to prove it. Stop by Booth 5069 (North Hall) for a first-hand look at the AuroraOne family of next-generation visible sources that enable more convenient, effective and cost-efficient systems.
While at the conference, don’t miss technical presentations about our latest innovations in performance and wavelengths during the LASE technical program on Monday, January 30 (papers 10088-1 and 10088-2) and Tuesday, January 31 (paper 10088-44).
To schedule an appointment with us during Photonics West, or to learn more about Norlase’s products, feel free to reach out at firstname.lastname@example.org.
We are proud to announce that Norlase has been funded under the EU H2020 phase 2 programme. Project CoDiS (Compact, high-power, frequency-converted Diode laser Systems) will accelerate the development of Norlase lasers in the yellow wavelength region. This will enable more affordable and accessible treatment of diabetic eye disease and other medical conditions. Diode laser manufacturer Eagleyard (GE) is a partner in the project, while the Ferdinand-Braun-Institut (GE) is a key sub-contractor. Leading Danish business newspaper Børsen brings this article on the funding and the opportunity to improve laser medical treatments worldwide (Danish only): http://borsen.dk/nyheder/avisen/artikel/11/152718/artikel.html
Norlase is about to embark on the next stage of our mission to revolutionize medical laser markets. This opens a key R&D engineering position in our company.
Are you motivated by taking on big technological challenges as part of a passionate team? Are you ready to join Demarks leading photonics start-up? Then you might be our new Laser R&D Engineer.
To see the full job post click here.
We are happy to announce two major innovation projects that will receive funding from the European Commission under the Eurostars programme. Eurostars focuses on international projects that result in fast market introduction of innovative products.
Project ViDiLas will utilize the unique Norlase laser technology to create a more cost-effective and compact eye-treatment system. The goal is to enable more accessible and effective treatment for over 500 million people suffering from age- and diabetes-related eye diseases. The consortium around ViDiLas includes laser medical device manufacturer Pantec (CH), tapered diode manufacturer Eagleyard (GE) and the light source research institution Ferdinand Braun Institut (GE).
Project GENESIS focuses on bringing the advantages of laser microscopy out of the lab and into point-of-care diagnostics. Norlase’s laser technology enables far more compact and cost-effective Ti:Sapphire laser systems, which in turn enables extremely precise and effective diagnosis through e.g. raman spectroscopy and light sheet microscopy. The project is carried out in collaboration with leading Ti:Sapphire laser manufacturer M Squared Lasers (GB) and the Technical University of Denmark, Department of Photonics (DK).
According to the Danish Eurostars Officer, Jens Peter Vittrup, Norlase’s success in the Eurostars programme is unheard of. “Both of Norlase’s projects were ranked in the international top 10, which has never happened for a Danish company before”, he states. “This result should to be seen in the context that over 300 applications were filed”.
For more on Norlase and Eurostars, check out this recent article on Danish startup media trendsonline: http://trendsonline.dk/2016/04/29/laser-virksomheden-norlase-opnar-stotte-til-hele-projekter-fra-eurostars/ (Danish only)
Visit Norlase at Photonics West 2016, to witness the world-premiere of the 561 nm Norlase AuroraOne laser. The newest member of the AuroraOne family offers new levels of convenience and the lowest cost-of-ownership for powerful, high-quality yellow-green lasers. It delivers up to 2 W of output power with M2 < 1.2 and modulation capability – all in a compact, air-cooled package. This enables manufacturers of medical laser equipment to design more convenient, effective and cost-efficient systems.
Norlase exhibits at Photonics West, the world’s #1 laser conference, which takes place in San Francisco’s Moscone Center from 16th – 18th of February 2016. Come by booth 5070 to hear more about the award-winning AuroraOne family of lasers and our mission to deliver truly convenient visible lasers. To learn about our exhibition and availability at Photonics West, feel free to reach out at email@example.com
When the world’s # 1 laser conference opens its doors in 2016, it will be with Norlase among the exhibitors. Photonics West 2016 takes place in San Francisco’s Moscone Center from 16th – 18th of February. For the first time ever, more than 20.000 conference attendees will have the chance to visit Norlase at booth #5070 and have a closer look at our products.
In addition to the friendly Norlase staff, the booth will feature live demonstrations of the award-winning AuroraOne family of lasers. AuroraOne brings unprecedented cost-effectiveness and flexibility to medical and bio-imaging applications – so come by booth 5070 to learn more about the next generation of visible lasers. To learn about our exhibition and availability at Photonics West, feel free to reach out at firstname.lastname@example.org
In start-December, Norlase was presented as one of three cases, posing as prime examples of how spinouts, collaborating with universities and local regions, can create tangible value for the society.
CEO Peter Skovgaard and Business Development Director Oliver Hvidt explains how Norlase is unique and adds value to the world.
Our technology encompasses the best of two worlds: The starting point is a strong and not least future-oriented technology. In addition, we are financially competitive as our laser is easy to produce and less expensive than competing products while also being highly efficient,” says Peter Skovgaard.
Follow the Link to watch CEO Peter Skovgaard and co-inventor Paul Michael Petersen talk about Norlase.
Holography News® ‘caught up’ with Nicklas Jarnel (Business Developer) and Dr Michelle Stock (Director of Business Development) from Norlase following the 10th International Symposium on Display Holography in St Petersburg, in July, where Norlase’s technology and future developments were presented.
Find the full article: Link
Norlase has recieved signficant financial support from the Danish Market Development Fund. The grant supports the development project COTIS (Compact TI:Sapphire laser system), with the aim of optimizing Norlase’s AuroraOne laser for pumping of laser systems for medical imaging and research. COTIS will be carried out in collaboration with femtosecond laser system manufacturer Femtolasers, medical device manufacturer Jenlab and the Technical University of Denmark.
The purpose of the Market Development Fund is to promote growth, employment and exports, particularly for small and medium-sized enterprises in areas where Denmark has particular strength and potential. Such areas include conversion to green technology, health and welfare solutions, design and other creative professions, etc.
“The most valuable part of this project, is the close collaboration with customers and end-users for our product. It helps us maximize the value we can create with AuroraOne” – Peter M.W. Skovgaard, CEO, Norlase
More details about the project can be found on the Market Devlopment Fund’s webpage (in danish)
At the World of Photonics conference in Munich, Norlase participated in the first edition of the Startup World Competition. The competition promotes the most promising new companies in the laser industry, which Norlase finished at an honourable 2nd place. If you want to learn more about Norlase, click the picture on your right, to see an interview from Munich with business developer Oliver Hvidt, explaining the technology.
After a successful conference, we at Norlase, would like to thank everyone we met and everyone who had time to visit our booth. If you would like to contact us, please do so at email@example.com
Norlase will be exhibiting in Munich at the World of Photonics conference from the 22nd to the 26th of June, in hall 3B, booth 528. Come meet us at our booth to learn more about our technology and to see our groundbreaking AuroraOne laser.
Norlase is nominated as one of 3 finalists in the first edition of The Startup World. Come meet us at the Award Ceremony, starting Wednesday 10:30 in hall A2 at the Optical Meteorology & Imaging Forum. At The Startup World Norlase will be pitching Wednesday at 14:20 and Thursday 10:20 in hall 3B at The Startup World Forum
For meeting-requests at the conference, please contact Nicklas Jarnel at firstname.lastname@example.org
Norlase is proud to announce that AuroraOne, our ultra-low noise visible laser, is the winner of the Technology Transfer Program at CLEO 2015.
CLEO is the world’s leading peer-reviewed meeting on photonics and the premier international forum for laser science and industry. Despite strong competition, Director of Business Development, Michelle L. Stock’s pitch won the prize as the best new technology at the 2015 Pitch Panel. To learn more about the benefits of the AuroraOne laser, contact us at email@example.com.
Norlase is currently exhibiting their ultra-compact AuroraOne laser, for the first time publically, at the CLEO conference in San Jose, California. The AuroraOne delivers high-brightness and low noise in wavelenghts such as 465, 488, 515 and 532nm, making it ideal for applications such as microscopy, high-throughput DNA sequencing and holography. Norlase is exhibiting at booth 2512 – come by to learn more.
At Thursday 14th of May, Director of Business Development at Norlase, Michelle L. Stock, will be presenting the Norlase technology, as part of the pitch panel at the Technology Transfer Program from 9:30-12:30 in the Exhibit Hall Theater(the pitch panel runs from 10:45-12.30). Come by to hear about Norlase’s revolutionizing technology.
CEO Peter Skovgaard will lead the Norlase delegation heading to the Photonics West conference from the 6th to the 13th of February.
The conference takes place in San Francisco, CA, being the years biggest industry event. We look forward to meeting our current and potential future partners in this inspiring setting.
Is your company also attending Photonics West? If you are interested in hearing more about the next generation of ultra-compact, high perfomance lasers, please contact Nicklas Jarnel at firstname.lastname@example.org for more about our schedule and availability.
Norlase has successfully completed a capital increase lead by investment company Capnova and supplemented by our current investors. Capnova’s investment strategy is focused on IT and food-tech, but they chose to partner with Norlase due to the potential of the technology and the strength of the team. Furthermore investment manager Cathal Mahon adds experience in scaling med-tech businesses to the team, as he enters the Norlase board of directors.
The capital increase enables Norlase to live up to the increasing demand for our products, by establishing new production facilities in Roskilde, Denmark. For additional information please reach out at email@example.com
After an exhilarating year, Norlase is now ready to make vital additions to the existing Norlase team.
Are you ready to play a key role in realizing the potential of one of Denmark’s most promising high-tech companies? Are you motivated by taking part in the kind of team spirit that can only be found in a high-growth start-up? Then you might be our new lead engineer.
To see the full job post click here
The Norlase team is pleased to announce a significant seed investment in our company from a danish business angel group consisting of Niels Korsholm, Kalle Hvidt Nielsen and Per Ibsen. This investment will enable Norlase to continue the development and pre-manufacturing phases of our compact laser light source, intended for medical, material processing and other industry applications. David Hardwick, Chairman of Norlase, commented; “Our new partners add both management and egineering skills to our team; as well as their financial investement. We are delighted to have them on board as we head toward the marketplace with our new lasers”
Rasmus Helveg Petersen, minster for Climate, Energy & Building recently visited our offices in the Green Entrepreneur House, along with the mayor of Roskilde and the president of the Danish Technical University.
The minister was particularly interested in the energy-saving potential of Norlase ‘s unique technological platform. CEO Peter Skovgaard introduced our company and explained why Norlase is poised to become Denmarks next green growth success story.
The picture on the right shows Peter presenting our ultra-compact 532.01.02 laser model. From left to right: Norlase CEO Peter Skovgaard, President of DTU Anders Bjarklev, minister for Climate, Energy and Building Rasmus Helveg Petersen, Mayor of Roskilde municipality Joy Mogensen.
A journlist from one of the largest danish newspapers, Berlingske Tidende, has recently visited Norlase to speak to CEO Peter Skovgaard, with the purpose of doing an article about Norlase.
The article has just been published, telling Norlase’s story, while giving an insight into CEO Peter Skovgaard’s ambitious vision for the future.
“My vision simply is to create the worlds best company, producing the worlds best laster. It may sound ambitious, but we have all the potential to do something that resonates internationally.”
The full article can be found in Berlingske Tidende’s business section dated 30/5, or online by following this link.
The Danish Technical University has also done a piece on Norlase recently, focused on how the “Bridging the Gap” innovation model has been key to our success. This article can be found via this link (Danish only).
Norlase has moved its offices out of DTU campus and into the high-tech incubator “Det Grønne Iværksætterhus” (the Green Entrepreneur House).
CEO Peter Skovgaard sees this as another step away from university spin-out and towards full-blown industrial supplier:
“We chose the Green Entrepreneur House as our new address because it fits perfectly with our strategy. Our new offices are both bigger and more modern than what we are used to, but what is really important is that it allows for further expansion of our operations. I am convinced that we have found the perfect place to continue our growth and move Norlase into the next phase.”
The Green Entrepreneur House is located in Risø Huse, conveniently close to DTU Risø. This allows Norlase to continue collaborating with leading researchers. The change of address has entered into force from the beginning of May.
An adventurous journey to San Fransisco is over for the Norlase team. The week got off to a great start, as CEO Peter Skovgaard qualified for the final of the SPIE Startup Challenge, with his 3-minute Norlase pitch. In the final, a strong perfomance earned Norlase a 3rd place in the peoples choice award.
San Fransisco provided the perfect venue for the Norlase launch reception the following evening. We would like to thank the many partners and freinds who showed up to celebrate.
The most important aspect of Photonics West was the constructive talks with a range of interesting industry players. While the conference gave us plenty of joyful memories to look back upon, the interest shown in our products has made us even more keen to look forward!”
The entire Norlase team is attending Photonics West 2014: SPIE Photonics West is the largest and most influential event for the laser and photonics community in North America: 20,000 attendees, two exhibitions, 1,240 exhibiting companies, a wide range of papers on biomedical optics, biophotonics, translational research, industrial lasers, optoelectronics, microfabrication, optical MEMS, and more.
Led by CEO Peter Skovgaard, the Norlase team is traveling 5,500 miles from Copenhagen to San Francisco. If you would like to meet us at PW and hear more about our groundbreaking laser technology and how we can help your company, we can be reached at firstname.lastname@example.org
Norlase has qualified for semi-finals of the SPIE Startup Challenge 2014. This fast-paced pitch competition invites new entrepreneurs to pitch their light-based technology product to a team of business development experts and venture capitalists. Norlase has been chosen among the top 25 teams for the semi-finals in San Fransisco on the 4th of February.
Despite having only 2 slides and 3 minutes to convince the judges, Norlase CEO Peter M. W. Skovgaard believes that his pitch has good chances of taking Norlase to the final. In the final 10.000 USD in cash prices and 5.000 USD in goods is up for grabs. The final is at 3:30 pm on 5th of February in Room 130 of the Moscone Center, San Francisco, California.
Registration for the event is free through www.spie.org.
A business plan for the Norlase technology was entered into the worlds biggest start-up competition, Venture Cup. The entry focused on the potential for Norlase on the market for laser dermatology treatments and was awarded a Booster Pack for being among the teams with the highest potential for growth. The “Booster Pack” secured sponsored goods and services, such as legal and accounting aid, website design and hosting, 500 high-caffeine sodas and more, for a collective value of over 400.000 DKK. Statements from the judges included:
“This is a business plan that addresses all important items. It obvious that this is a very mature team that knows its own strengths and apparently very few weaknesses. It is not easy to come with further recommendations”.
“The product is very clearly described, the team has made good progress and seems to have drive and potential to reach the market”.
“Over all a good plan and very realistic and proffessional approach – Good!”